Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells

Human Immunology

Volumn 72, Issue 1, 2011, Pages 24-31

  Paustian, Christopher ^a,b   Caspell, Richard ^b   Johnson, Terrence ^b   Cohen, Peter A ^b   Shu, Suyu ^b   Xu, Shuwen ^c   Czerniecki, Brian J ^c   Koski, Gary K ^a  

^a KENT STATE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dendritic cell; IL 12; Innate immunity; T helper cell; Toll like receptor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD40 LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL STIMULATION; CLINICAL ASSESSMENT; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL;

ANTIGENS, SURFACE; CD40 LIGAND; CELL POLARITY; CYTOKINES; DENDRITIC CELLS; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; PHENOTYPE; TH1 CELLS; TOLL-LIKE RECEPTORS;

EID: 78650171346     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.10.004     Document Type: Article

References (25)

1. Kalinski P., Hilkens C.M., Wierenga E.A., Kapsenberg M.L. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal. Immunol Today 1999, 20:561-567.
2. Zinkernagel R.M., Doherty P.C. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature 1974, 251:547-548.
3. Linsley P.S., Clark E.A., Ledbetter J.A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci U S A 1990, 87:5031-5035.
4. Reiser H., Freeman G.J., Razi-Wolf Z., Gimmi C.D., Benacerraf B., Nadler L.M. Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex. Proc Natl Acad Sci U S A 1992, 89:271-275.
5. Kalinski P. Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4. Curr Opin Investig Drugs 2009, 10:526-535.
6. Scott P. IL-12: Initiation cytokine for cell-mediated immunity. Science 1993, 260:496-497.
7. Pulendran B. Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunol Res 2004, 29:187-196.
8. Bui J.D., Schreiber R.D. Cancer immunosurveillance, immunoediting and inflammation: Independent or interdependent processes?. Curr Opin Immunol 2007, 19:203-208.
9. Snijders A., Kalinski P., Hilkens C.M., Kapsenberg M.L. High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 1998, 10:1593.
10. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005, 6:769-776.
11. Jurk M., Heil F., Vollmer J., Schetter C., Krieg A.M., Wagner H., et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002, 3:499.
12. Kawai T., Sato S., Ishii K.J., Coban C., Hemmi H., Yamamoto M., et al. Interferon-alpha induction through toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004, 5:1061-1068.
13. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999, 274:10689-10692.
14. Hoebe K., Janssen E.M., Kim S.O., Alexopoulou L., Flavell R.A., Han J., Beutler B. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 2003, 4:1223-1229.
15. - and TRIF-dependent activation program of dendritic cells. Eur J Immunol 2004, 34:558-564.
16. Mosca P.J., Hobeika A.C., Clay T.M., Nair S.K., Thomas E.K., Morse M.A., Lyerly H.K. A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment. Blood 2000, 96:3499-3504.
17. Langenkamp A., Messi M., Lanzavecchia A., Sallusto F. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 2000, 1:311-316.
18. Czerniecki B.J., Koski G.K., Koldovsky U., Xu S., Cohen P.A., Mick R., et al. Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res 2007, 67:1842-1852.
19. + T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism. J Immunol 2003, 171:2551-2561.
20. Koski G.K., Kariko K., Xu S., Weissman D., Cohen P.A., Czerniecki B.J. Cutting edge: Innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J Immunol 2004, 172:3989-3993.
21. Kalinski P., Schuitemaker J.H., Hilkens C.M., Wierenga E.A., Kapsenberg M.L. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: Decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J Immunol 1999, 162:3231-3236.
22. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994, 179:1109-1118.
23. Berger M., Ablasser A., Kim S., Bekeredjian-Ding I., Giese T., Endres S., et al. TLR8-driven IL-12-dependent reciprocal and synergistic activation of NK cells and monocytes by immunostimulatory RNA. J Immunother 2009, 32:262-271.
24. Lauzon N.M., Mian F., MacKenzie R., Ashkar A.A. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol 2006, 241:102-112.
25. Wolf S.F., Temple P.A., Kobayashi M., Young D., Dicig M., Lowe L., et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991, 146:3074-3081.